Navigation Links
Beyond DTC: Pharma Industry Faces New Challenges, Competition, Strategies for Market Dominance
Date:1/15/2008

NEW YORK, Jan. 15 /PRNewswire/ -- As drastic cutbacks at major pharmaceuticals continue, competition soars from generics and challenge blockbuster drug teams. Social networks have entered the zone of physician and patient encounters. Advertising expenditures are being scrutinized for ROI. Product recalls and drug safety warnings pose new issues and responsibilities on drug marketers. Yet new marketing opportunities have opened up with the growth of multicultural segments, new technologies, media channels and sales force optimization tools.

This year's 2nd Annual Pharmaceutical Sales & Marketing Executive Congress, scheduled for March 31 - April 1, 2008 in Bethesda, Maryland brings together an impressive line-up of experts and industry leaders who will outline trends, case studies, and best-practices required to reformulate pharmaceutical marketing and sales strategies in the light of the new rules of engagement in this industry. Speaking faculty includes:

-- Hon. Gene Green (D-TX), Member, Health Subcommittee - Energy & Commerce

Committee, U. S. House of Representatives

-- Paul J. Savidge, VP, Global Labeling & Compliance, Bristol-Myers Squibb

-- Liliana A. Gil, Worldwide Director of Marketing Services & Hispanic

Strategy Lead, Johnson & Johnson

-- Ellen Shapiro, Director, Division of Communications, Center for Drug

Evaluation and Research (CDER), FDA

-- David Lampinski, Associate Director, Commercial Analytics, Sepracor

Inc.

-- Jeannie Miller, Managed Markets, Jazz Pharmaceuticals

-- Glenn Byrd, VP, Regulatory Affairs, MedImmune

-- Chris Bogan, CEO, Best Practices LLC

-- John Mack, Publisher, Pharma Marketing News

-- Robin L. Winter-Sperry, M.D., President & CEO, Scientific Advantage

-- Nayan Shah M.D., Associate Professor of Medicine, Georgetown University

Medical Center

-- Hugo Stephenson, M.D., President, iGuard.Org

-- Jan Malek, Director, IDSG-Life Sciences, Cisco Systems

-- John S. Lenart, Senior Brand Director, Arestin(R), OraPharma, Inc.

-- Ilyssa Levins, President, Center for Communication Compliance and HCIL

Healthcare Consulting

-- Harry Sweeney, Chairman and CEO, Dorland Global Health Communications

Group

-- Kathy Kastner, CEO, The Health Television System

-- Ed Silverman, Founder, Pharmalot & Award-Winning Journalist, New Jersey

Star Ledger

-- Mark Bard, President, Manhattan Research

For Complete List of Speakers, Detailed Agenda, and to Register: http://www.iibig.com/P0802

Call: 212-300-2523

E-mail: rial@iibig.com


'/>"/>
SOURCE iiBIG
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments
2. Out beyond the horizon
3. Out beyond the horizon
4. SAFC Pharma to Increase Viral Product Manufacturing Capacity
5. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
6. A New, Unique and Unrivalled Rat/Mouse PINP Assay for Pharmaceutical, Clinical and Academic Research Organizations.
7. Cantox Announces the Launch of Ashuren Health Sciences Pharmaceutical Division
8. PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
9. ViroPharma Provides 2008 Outlook
10. Anadys Pharmaceuticals to Present at the JPMorgan Healthcare Conference
11. Cerimon Pharmaceuticals Names Matthew J. Meyer its General Counsel and Vice President of Business Development and Licensing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016   EpiBiome , a precision microbiome engineering ... debt financing from Silicon Valley Bank (SVB). The financing ... advance its drug development efforts, as well as purchase ... "SVB has been an incredible strategic partner to us ... bank would provide," said Dr. Aeron Tynes Hammack ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today in ... patient who developed lymphedema after being treated for breast cancer benefitted from an injection ... for dealing with this debilitating, frequent side effect of cancer treatment. , ...
(Date:6/23/2016)... , June 23, 2016 ... Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published ... the peer-reviewed journal from touchONCOLOGY, Andrew D ... cost of cancer care is placing an increasing ... of expensive biologic therapies. With the patents on ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
Breaking Biology Technology:
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... customers enhanced security to access and transact across ...
(Date:4/14/2016)... TEL AVIV, Israel , April 14, 2016 /PRNewswire/ ... in Behavioral Authentication and Malware Detection, today announced the ... has already assumed the new role. Goldwerger,s ... for BioCatch, on the heels of the deployment of ... In addition, BioCatch,s behavioral biometric technology, which discerns unique ...
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
Breaking Biology News(10 mins):